GB0505205D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0505205D0
GB0505205D0 GB0505205A GB0505205A GB0505205D0 GB 0505205 D0 GB0505205 D0 GB 0505205D0 GB 0505205 A GB0505205 A GB 0505205A GB 0505205 A GB0505205 A GB 0505205A GB 0505205 D0 GB0505205 D0 GB 0505205D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0505205A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0505205A priority Critical patent/GB0505205D0/en
Publication of GB0505205D0 publication Critical patent/GB0505205D0/en
Priority to AU2006224440A priority patent/AU2006224440A1/en
Priority to PCT/GB2006/000846 priority patent/WO2006097691A1/en
Priority to KR1020077020994A priority patent/KR20070113225A/en
Priority to JP2008501397A priority patent/JP2008533117A/en
Priority to MX2007011211A priority patent/MX2007011211A/en
Priority to ES06710058T priority patent/ES2321028T3/en
Priority to AT06710058T priority patent/ATE420091T1/en
Priority to DE602006004714T priority patent/DE602006004714D1/en
Priority to CNA2006800155148A priority patent/CN101171256A/en
Priority to EA200701984A priority patent/EA200701984A1/en
Priority to EP06710058A priority patent/EP1858900B1/en
Priority to BRPI0608437-0A priority patent/BRPI0608437A2/en
Priority to US11/908,532 priority patent/US20080161289A1/en
Priority to CA002601644A priority patent/CA2601644A1/en
Priority to ZA200707386A priority patent/ZA200707386B/en
Priority to IL185869A priority patent/IL185869A0/en
Priority to MA30235A priority patent/MA29339B1/en
Priority to NO20074977A priority patent/NO20074977L/en
Ceased legal-status Critical Current

Links

GB0505205A 2005-03-14 2005-03-14 Novel compounds Ceased GB0505205D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0505205A GB0505205D0 (en) 2005-03-14 2005-03-14 Novel compounds
CA002601644A CA2601644A1 (en) 2005-03-14 2006-03-10 Fused thiazole derivatives having affinity for the histamine h3 receptor
DE602006004714T DE602006004714D1 (en) 2005-03-14 2006-03-10 CONDENSED THIAZONE DERIVATIVES WITH AFFINITY FOR THE HISTAMINE H3 RECEPTOR
EA200701984A EA200701984A1 (en) 2005-03-14 2006-03-10 CONDENSED TIAZOLE DERIVATIVES THAT HAVE A COMPLEX FOR HISTAMINE H3 RECEPTOR
KR1020077020994A KR20070113225A (en) 2005-03-14 2006-03-10 Fused thiazole derivatives having affinity for the histamine h3 receptor
JP2008501397A JP2008533117A (en) 2005-03-14 2006-03-10 Condensed thiazole derivatives having affinity for histamine H3 receptor
MX2007011211A MX2007011211A (en) 2005-03-14 2006-03-10 Fused thiazole derivatives having affinity for the histamine h3 receptor.
ES06710058T ES2321028T3 (en) 2005-03-14 2006-03-10 CONDENSED TIAZOL DERIVATIVES THAT HAVE AFFINITY FOR THE H3 HISTAMINE RECEIVER.
AT06710058T ATE420091T1 (en) 2005-03-14 2006-03-10 CONDENSED THIAZOLE DERIVATIVES WITH AFFINITY FOR THE HISTAMINE H3 RECEPTOR
AU2006224440A AU2006224440A1 (en) 2005-03-14 2006-03-10 Fused thiazole derivatives having affinity for the histamine H3 receptor
CNA2006800155148A CN101171256A (en) 2005-03-14 2006-03-10 Fused thiazole derivatives having affinity for the histamine h3 receptor
PCT/GB2006/000846 WO2006097691A1 (en) 2005-03-14 2006-03-10 Fused thiazole derivatives having affinity for the histamine h3 receptor
EP06710058A EP1858900B1 (en) 2005-03-14 2006-03-10 Fused thiazole derivatives having affinity for the histamine h3 receptor
BRPI0608437-0A BRPI0608437A2 (en) 2005-03-14 2006-03-10 fused thiazole derivatives that have histamine h3 receptor affinity
US11/908,532 US20080161289A1 (en) 2005-03-14 2006-03-10 Fused Thiazole Derivatives Having Affinity for the Histamine H3 Receptor
ZA200707386A ZA200707386B (en) 2005-03-14 2007-08-30 Fused thiazole derivatives having affinity for the histamine H3 receptor
IL185869A IL185869A0 (en) 2005-03-14 2007-09-10 Fused thiazole derivatives having affinity for the histamine h3 receptor
MA30235A MA29339B1 (en) 2005-03-14 2007-09-24 FUSED THIAZOLE DERIVATIVES WITH AFFINITY FOR HISTAMINE H3 RECEPTOR
NO20074977A NO20074977L (en) 2005-03-14 2007-10-02 Fused thiazole derivatives with affinity for the histamine H3 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0505205A GB0505205D0 (en) 2005-03-14 2005-03-14 Novel compounds

Publications (1)

Publication Number Publication Date
GB0505205D0 true GB0505205D0 (en) 2005-04-20

Family

ID=34509032

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0505205A Ceased GB0505205D0 (en) 2005-03-14 2005-03-14 Novel compounds

Country Status (3)

Country Link
CN (1) CN101171256A (en)
GB (1) GB0505205D0 (en)
ZA (1) ZA200707386B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103819478B (en) * 2014-03-21 2016-05-04 成都诺维尔生物医药有限公司 The preparation method of my Ge Lieting intermediate 2-methyl-pyrazolo [1,5-A] pyrimidine-6-carboxylic acid

Also Published As

Publication number Publication date
ZA200707386B (en) 2008-09-25
CN101171256A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
EP1866311A4 (en) Novel compounds
EP1868612A4 (en) Novel compounds
EP1868611A4 (en) Novel compounds
GB0503955D0 (en) Novel compounds
EP1869026A4 (en) Novel compounds
GB0500140D0 (en) Novel compounds
GB0505205D0 (en) Novel compounds
GB0504098D0 (en) Novel compounds
GB0500285D0 (en) Novel compounds
GB0500887D0 (en) Novel compounds
GB0500886D0 (en) Novel compounds
GB0500920D0 (en) Novel compounds
GB0500921D0 (en) Novel compounds
GB0500885D0 (en) Novel compounds
GB0500884D0 (en) Novel compounds
GB0500883D0 (en) Novel compounds
GB0500839D0 (en) Novel polyacetylen compounds
GB0504109D0 (en) Novel compounds
GB0500406D0 (en) Novel compounds
GB0504108D0 (en) Novel compounds
GB0504107D0 (en) Novel compounds
GB0504099D0 (en) Novel compounds
GB0501094D0 (en) Novel compounds
GB0500923D0 (en) Novel compounds
GB0500513D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)